Spero Therapeutics

Entity > Corporation > US > New York City New York > Spero Therapeutics

About Spero Therapeutics

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Spero Therapeutics

Company Attribute Value
Address StreetAddress: 675 Massachusetts Ave Fl 14, AddressLocality: Cambridge, AddressRegion: Massachusetts, PostalCode: 2139, AddressCountry: United States
Founding Date 2013
Name Spero Therapeutics
Number Of Employees 35
Revenue $13,025,000 USD
Ticker Symbol NASDAQ: SPRO
Url sperotherapeutics
Facebook facebook
Linkedin linkedin
Twitter twitter
Google google
Wikidata wikidata

Spero Therapeutics

us

New York City, US
17 Apr 2024

New York City, US
17 Apr 2024

Spero Therapeutics

All
News
Images
Maps
Videos
More
Page: 1 Desktop | Laptop Devices
https://www.sperotherapeutics.com/
Spero Therapeutics | Developing MDR Bacterial Infection ...
Spero Therapeutics is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for ...
Rich Sitelinks
Rich Sitelinks
https://finance.yahoo.com › quote › SPRO
Spero Therapeutics, Inc. (SPRO) Stock Price, News, Quote ...
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for ...
People Also Ask
People Also Ask
https://twitter.com/Spero_Tx?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Spero Therapeutics (@Spero_Tx) · X
Twitter Boxes
Twitter Boxes
https://www.marketwatch.com › ... › United States
Spero Therapeutics Inc. Stock Quote (U.S. - SPRO
SPRO | Complete Spero Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
https://www.linkedin.com/company/spero-therapeutics
Spero Therapeutics
We are a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for ...
https://www.pfizer.com › news › press-release-detail › s...
Spero Therapeutics Announces $40 Million Equity ...
Jun 30, 2021 — (NYSE: PFE) has made a $40 million equity investment in Spero as part of the Pfizer Breakthrough Growth Initiative, a program focused on funding ...
https://www.biospace.com › employer › spero-therapeu...
Articles about Spero Therapeutics
197 articles about Spero Therapeutics. Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Business Update.
Related Searches
Related Searches
Spero therapeutics fda approval
spero therapeutics layoffs
spero therapeutics news
Knowledge Panel
Knowledge Panel

Spero Therapeutics (Biotech company)

sperotherapeutics.com/

  • Stock price : SPRO (NASDAQ) $1.50 +0.03 (+2.04%)Apr 17, 3:58 PM EDT - Disclaimer
  • Headquarters : Massachusetts
  • President : Ankit Mahadevia
  • Founded : 2013

Related Entities Spero Therapeutics

Entity Home Kalicube Pro Entity Page
Spero Therapeutics Entity Home Spero Therapeutics on Kalicube
Ginkgo Bioworks Entity Home Ginkgo Bioworks on Kalicube
Zymergen Entity Home Zymergen on Kalicube

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 194056